“The cell culture market is projected to reach USD 18,630.7 million by 2020 from USD 11,310.9 million in 2015, at a CAGR of 10.5%. This market is categorized on the basis of products, applications, end users, and regions.
Major factors contributing to the growth of the global cell culture market include the increasing incidence of chronic diseases, growth in number of regulatory approvals for cell culture-based vaccines, growing demand for mAbs, funding for cell-based research, rising adoption of single-use technologies, and technological advancements in cell culture products. However, factors such as high cost of research in cell biology and lack of infrastructure for cell-based research are likely to hinder the growth of this market during the forecast period.
The cell culture market in Asia is expected to witness the highest growth rate from 2015-2020. Emerging economies such as China and India preferred destinations for major pharmaceutical giants as the cost of production is significantly lower compared to developed nations. Moreover, regulatory norms in these countries are less stringent and the cost of labor is less. This in turn reduces the cost of production of biologics. Owing to these benefits, various pharmaceutical giants are actively investing in these markets to develop biopharmaceutical drugs. For instance, in June 2013, Boehringer Ingelheim (Germany) invested €35 million (USD 46.4 million) to establish a cGMP biopharmaceutical manufacturing facility in China.
Apart from the comprehensive regional analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. The company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The above mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of top players in the cell culture market. The report analyzes the cell culture market by product, applications, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the cell culture market
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the cell culture market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for cell culture market across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the cell culture market
”
“TABLE OF CONTENTS
1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATION 22
1.6 STAKE HOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 MARKET SIZE ESTIMATION 25
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.3 KEY INDUSTRY INSIGHTS 30
2.4 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 CELL CULTURE MARKET OVERVIEW 36
4.2 CELL CULTURE VESSELS MARKET 37
4.3 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET 38
4.4 CELL CULTURE MARKET, BY APPLICATION 39
4.5 CELL CULTURE MARKET, BY END USER 39
4.6 CELL CULTURE MARKET: GEOGRAPHIC SNAPSHOT 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET SEGMENTATION 42
5.2.1 BY PRODUCT 42
5.2.1.1 BY EQUIPMENT 43
5.2.1.2 BY CONSUMABLE 43
5.2.2 BY APPLICATION 44
5.2.3 BY END USER 44
5.2.4 BY REGION 44
5.3 MARKET DYNAMICS 45
5.3.1 MARKET DRIVERS 46
5.3.1.1 Growing awareness on the benefits of, and rising regulatory approvals for, cell culture-based vaccines 46
5.3.1.2 Increase in demand for monoclonal antibodies (mAbs) 46
5.3.1.3 Funding for cell-based research 46
5.3.1.4 Growing preference for single-use technologies 47
5.3.1.5 Technological advancements 47
5.3.2 MARKET RESTRAINTS 48
5.3.2.1 High cost of cell biology research 48
5.3.2.2 Lack of infrastructure for cell-based research in emerging economies 48
5.3.3 MARKET OPPORTUNITIES 49
5.3.3.1 3D cell culture 49
5.3.3.2 Increased risk of pandemics and communicable diseases 49
5.3.3.3 Emerging Economies 50
5.3.4 MARKET CHALLENGES 50
5.3.4.1 Survival of new entrants 50
6 CELL CULTURE MARKET, BY PRODUCT 51
6.1 INTRODUCTION 52
6.2 EQUIPMENT 53
6.2.1 BIOREACTORS 55
6.2.1.1 Conventional bioreactors 56
6.2.1.2 Single-use bioreactors 57
6.2.2 CELL CULTURE VESSELS 59
6.2.2.1 Flasks 60
6.2.2.2 Roller/Roux Bottles 61
6.2.2.3 Cell Factory Systems/Cell Stacks 62
6.2.2.4 Petri Dishes 63
6.2.2.5 Multiwell plates 64
6.2.3 CELL CULTURE STORAGE EQUIPMENT 65
6.2.3.1 Refrigerators and Freezers 67
6.2.3.2 Cryostorage Systems 68
6.2.4 CELL CULTURE SUPPORTING EQUIPMENT 70
6.2.4.1 Cell Counters 71
6.2.4.2 Filtration Systems 73
6.2.4.3 Centrifuges 74
6.2.4.4 CO2 Incubators 75
6.2.4.5 Autoclaves 77
6.2.4.6 Microscopes 78
6.2.4.7 Biosafety Cabinets 79
6.2.4.8 Other Cell Culture Supporting Equipment 80
6.3 CONSUMABLES 82
6.3.1 SERA, MEDIA, AND REAGENTS 84
6.3.1.1 Sera 85
6.3.1.1.1 Fetal Bovine Sera (FBS) 87
6.3.1.1.2 Adult Bovine Sera (ABS) 89
6.3.1.1.3 Other Animal Sera 90
6.3.1.2 Media 91
6.3.1.2.1 Classical Media & Salts 92
6.3.1.2.2 Serum-free media 93
6.3.1.2.3 Specialty media 94
6.3.1.2.4 Stem cell culture media 95
6.3.1.3 Reagents 97
6.3.1.3.1 Supplements and growth factors 98
6.3.1.3.2 Buffers and chemicals 99
6.3.1.3.3 Cell dissociation reagents 100
6.3.1.3.4 Balanced salt solutions 102
6.3.1.3.5 Cryoprotective reagents 103
6.3.1.3.6 Contamination detection kits 104
6.3.1.3.7 Antibiotics/Antimycotics 105
6.3.1.3.8 Attachment & Matrix factors 106
6.3.1.3.9 Other reagents 107
6.3.2 BIOREACTOR ACCESSORIES 108
7 CELL CULTURE MARKET, BY APPLICATION 109
7.1 INTRODUCTION 110
7.2 BIOPHARMACEUTICAL/THERAPEUTIC APPLICATIONS 111
7.2.1 VACCINE PRODUCTION 112
7.2.2 DIAGNOSTICS 114
7.2.3 RECOMBINANT THERAPEUTIC PROTEINS 115
7.3 CANCER RESEARCH 116
7.4 STEM CELL TECHNOLOGIES 118
7.5 DRUG SCREENING & DEVELOPMENT 119
7.6 TISSUE ENGINEERING & REGENERATIVE MEDICINE 120
7.7 OTHER APPLICATIONS 121
8 CELL CULTURE MARKET, BY END USER 123
8.1 INTRODUCTION 124
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 125
8.3 RESEARCH INSTITUTES 126
9 CELL CULTURE MARKET, BY REGION 128
9.1 INTRODUCTION 129
9.2 NORTH AMERICA 131
9.2.1 U.S. 138
9.2.2 CANADA 144
9.3 EUROPE 150
9.4 ASIA 158
9.5 REST OF THE WORLD (ROW) 166
10 COMPETITIVE LANDSCAPE 174
10.1 OVERVIEW 174
10.2 MARKET SHARE ANALYSIS 176
10.3 COMPETITIVE SITUATION AND TRENDS 177
10.3.1 NEW PRODUCT LAUNCHES 178
10.3.2 AGREEMENTS AND COLLABORATIONS 179
10.3.3 EXPANSIONS 180
10.3.4 ACQUISITIONS 181
11 COMPANY PROFILES 182
11.1 INTRODUCTION 182
11.2 THERMO FISHER SCIENTIFIC, INC. 183
11.3 MERCK KGAA 191
11.4 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 200
11.5 LONZA GROUP AG 205
11.6 CORNING, INC. 209
11.7 BECTON, DICKINSON AND COMPANY 219
11.8 EPPENDORF AG 223
11.9 HI-MEDIA LABORATORIES 228
11.10 SARTORIUS AG 235
11.11 PROMOCELL GMBH 239
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
12 APPENDIX 241
12.1 INSIGHTS FROM INDUSTRY EXPERTS 241
12.2 DISCUSSION GUIDE 242
12.3 OTHER DEVELOPMENTS 245
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 251
12.5 AVAILABLE CUSTOMIZATION 251
12.6 RELATED REPORTS 252
“
“LIST OF TABLES
TABLE 1 U.S. GOVERNMENT FUNDING FOR STEM CELL RESEARCH 47
TABLE 2 GROWING AWARENESS ON THE BENEFITS OF CELL-CULTURE BASED VACCINES: A MAJOR DRIVER FOR MARKET GROWTH 48
TABLE 3 HIGH COST OF CELL BIOLOGY RESEARCH A MAJOR RESTRAIN FOR MARKET GROWTH 49
TABLE 4 EMERGING 3D CELL CULTURE TECHNOLOGIES, DEVELOPING ECONOMIES EXPECTED TO OFFER HIGH GROWTH OPPORTUNITIES 50
TABLE 5 SURVIVAL OF NEW ENTRANTS IN CELL CULTURE MARKET, A MAJOR CHALLENGE TO MARKET GROWTH 50
TABLE 6 GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 52
TABLE 7 CELL CULTURE EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 54
TABLE 8 CELL CULTURE EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 54
TABLE 9 NORTH AMERICA: CELL CULTURE EQUIPMENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 54
TABLE 10 BIOREACTORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 55
TABLE 11 BIOREACTORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 56
TABLE 12 NORTH AMERICA: BIOREACTORS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 56
TABLE 13 CONVENTIONAL BIOREACTORS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 57
TABLE 14 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 57
TABLE 15 SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 58
TABLE 16 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 58
TABLE 17 CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 59
TABLE 18 CELL CULTURE VESSELS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 60
TABLE 19 NORTH AMERICA: CELL CULTURE VESSELS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 60
TABLE 20 CELL CULTURE FLASKS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 61
TABLE 21 NORTH AMERICA: CELL CULTURE FLASKS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 61
TABLE 22 ROLLER BOTTLES/ROUX BOTTLES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 62
TABLE 23 NORTH AMERICA: ROLLER BOTTLES/ROUX BOTTLES MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 62
TABLE 24 CELL FACTORY/CELL STACKS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 63
TABLE 25 NORTH AMERICA: CELL FACTORY/CELL STACKS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 63
TABLE 26 PETRI DISHES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 64
TABLE 27 NORTH AMERICA: PETRI DISHES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 64
TABLE 28 MULTIWELL PLATES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 65
TABLE 29 NORTH AMERICA: MULTIWELL PLATES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 65
TABLE 30 CELL CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 66
TABLE 31 CELL CULTURE STORAGE EQUIPMENT MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 66
TABLE 32 NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 67
TABLE 33 REFRIGERATORS & FREEZERS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 67
TABLE 34 NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 68
TABLE 35 CRYOSTORAGE SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 69
TABLE 36 NORTH AMERICA: CRYOSTORAGE SYSTEMS SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 69
TABLE 37 CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 70
TABLE 38 CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 71
TABLE 39 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE,
BY COUNTRY 2013-2020 (USD MILLION) 71
TABLE 40 CELL COUNTERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 72
TABLE 41 NORTH AMERICA: CELL COUNTERS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 72
TABLE 42 FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 73
TABLE 43 NORTH AMERICA: FILTRATION SYSTEMS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 73
TABLE 44 CENTRIFUGES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 74
TABLE 45 NORTH AMERICA: CENTRIFUGES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 75
TABLE 46 CO2 INCUBATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 76
TABLE 47 NORTH AMERICA: CO2 INCUBATORS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 76
TABLE 48 AUTOCLAVES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 77
TABLE 49 NORTH AMERICA: AUTOCLAVES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 77
TABLE 50 MICROSCOPES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 78
TABLE 51 NORTH AMERICA: MICROSCOPES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 78
TABLE 52 BIOSAFETY CABINETS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 79
TABLE 53 NORTH AMERICA: BIOSAFETY CABINETS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 80
TABLE 54 OTHER CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 81
TABLE 55 NORTH AMERICA: OTHER CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 81
TABLE 56 CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE, 2013-2015 (USD MILLION) 82
TABLE 57 CELL CULTURE CONSUMABLES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 83
TABLE 58 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 83
TABLE 59 SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 84
TABLE 60 SERA, MEDIA, AND REAGENTS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 84
TABLE 61 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 85
TABLE 62 SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 86
TABLE 63 SERA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 87
TABLE 64 NORTH AMERICA: SERA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 87
TABLE 65 FETAL BOVINE SERA (FBS) MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 88
TABLE 66 NORTH AMERICA: FETAL BOVINE SERA MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 88
TABLE 67 ADULT BOVINE SERA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 89
TABLE 68 NORTH AMERICA: ADULT BOVINE SERA MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 89
TABLE 69 OTHER ANIMAL SERA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 90
TABLE 70 NORTH AMERICA: OTHER ANIMAL SERA MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 90
TABLE 71 MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 91
TABLE 72 MEDIA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 91
TABLE 73 NORTH AMERICA: MEDIA MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 92
TABLE 74 CLASSICAL MEDIA & SALTS, MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 92
TABLE 75 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 93
TABLE 76 SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 94
TABLE 77 NORTH AMERICA: SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 94
TABLE 78 SPECIALTY MEDIA MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 95
TABLE 79 NORTH AMERICA: SPECIALTY MEDIA MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 95
TABLE 80 STEM CELL CULTURE MEDIA MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 96
TABLE 81 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 96
TABLE 82 REAGENTS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 97
TABLE 83 REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 98
TABLE 84 NORTH AMERICA: REAGENTS MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 98
TABLE 85 SUPPLEMENTS AND GROWTH FACTORS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 99
TABLE 86 NORTH AMERICA: SUPPLEMENTS AND GROWTH FACTORS MARKET SIZE,
BY COUNTRY, 2013–2020 (USD MILLION) 99
TABLE 87 BUFFERS & CHEMICALS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 100
TABLE 88 NORTH AMERICA: BUFFERS & CHEMICALS MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 100
TABLE 89 CELL DISSOCIATION REAGENTS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 101
TABLE 90 NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 101
TABLE 91 BALANCED SALT SOLUTIONS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 102
TABLE 92 NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 102
TABLE 93 CRYOPROTECTIVE REAGENTS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 103
TABLE 94 NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 103
TABLE 95 CONTAMINATION DETECTION KITS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 104
TABLE 96 NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 104
TABLE 97 ANTIBIOTICS/ANTIMYCOTICS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 105
TABLE 98 ANTIBIOTICS/ANTIBIOTICS MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 105
TABLE 99 ATTACHMENT & MATRIX FACTORS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 106
TABLE 100 NORTH AMERICA: ATTACHMENT & MATRIX FACTORS, MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 106
TABLE 101 OTHER REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 107
TABLE 102 NORTH AMERICA: OTHER REAGENTS MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 107
TABLE 103 BIOREACTOR ACCESSORIES MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 108
TABLE 104 NORTH AMERICA: BIOREACTOR ACCESSORIES MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 108
TABLE 105 CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 110
TABLE 106 BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 111
TABLE 107 BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 112
TABLE 108 NORTH AMERICA: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 112
TABLE 109 VACCINE PRODUCTION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 113
TABLE 110 NORTH AMERICA: VACCINE PRODUCTION MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 113
TABLE 111 DIAGNOSTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 114
TABLE 112 NORTH AMERICA: DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 114
TABLE 113 RECOMBINANT THERAPEUTIC PROTEINS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 115
TABLE 114 NORTH AMERICA: RECOMBINANT THERAPEUTIC PROTEINS MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 116
TABLE 115 CANCER RESEARCH MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 117
TABLE 116 NORTH AMERICA: CANCER RESEARCH MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 117
TABLE 117 STEM CELL TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 118
TABLE 118 NORTH AMERICA: STEM CELL TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 118
TABLE 119 DRUG SCREENING & DEVELOPMENT MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 119
TABLE 120 NORTH AMERICA: DRUG SCREENING & DEVELOPMENT MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 119
TABLE 121 TISSUE ENGINEERING & REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 120
TABLE 122 NORTH AMERICA: TISSUE REGENERATION & REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 121
TABLE 123 OTHER APPLICATIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 122
TABLE 124 NORTH AMERICA: OTHER APPLICATIONS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 122
TABLE 125 CELL CULTURE MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 124
TABLE 126 CELL CULTURE MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2013–2020 (USD MILLION) 125
TABLE 127 NORTH AMERICA: CELL CULTURE MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013–2020 (USD MILLION) 125
TABLE 128 CELL CULTURE MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION,
2013–2020 (USD MILLION) 126
TABLE 129 NORTH AMERICA: CELL CULTURE MARKET SIZE FOR RESEARCH INSTITUTES,
BY COUNTRY, 2013–2020 (USD MILLION) 127
TABLE 130 GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 130
TABLE 131 NORTH AMERICA: CELL CULTURE MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 130
TABLE 132 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT,
2013-2020 (USD MILLION) 132
TABLE 133 NORTH AMERICA: CELL CULTURE MARKET SIZE, BY EQUIPMENT,
2013-2020 (USD MILLION) 132
TABLE 134 NORTH AMERICA: BIOREACTORS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 132
TABLE 135 NORTH AMERICA: CELL CULTURE VESSELS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 133
TABLE 136 NORTH AMERICA: CELL-CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 133
TABLE 137 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET SIZE,
BY TYPE, 2013-2020 (USD MILLION) 134
TABLE 138 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 134
TABLE 139 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 135
TABLE 140 NORTH AMERICA: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 135
TABLE 141 NORTH AMERICA: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 135
TABLE 142 NORTH AMERICA: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 136
TABLE 143 NORTH AMERICA: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 136
TABLE 144 NORTH AMERICA: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE,
BY APPLICATION, 2013-2020 (USD MILLION) 137
TABLE 145 NORTH AMERICA: CELL CULTURE MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 137
TABLE 146 U.S.: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION) 138
TABLE 147 U.S.: CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2013-2020 (USD MILLION) 139
TABLE 148 U.S.: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 139
TABLE 149 U.S.: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 139
TABLE 150 U.S.: CELL-CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 140
TABLE 151 U.S.: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 140
TABLE 152 U.S.: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 141
TABLE 153 U.S.: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 141
TABLE 154 U.S.: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 141
TABLE 155 U.S.: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 142
TABLE 156 U.S.: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 142
TABLE 157 U.S.: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 143
TABLE 158 U.S.: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 143
TABLE 159 U.S.: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 143
TABLE 160 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION) 144
TABLE 161 CANADA: CELL CULTURE MARKET SIZE, BY EQUIPMENTS,
2013-2020 (USD MILLION) 144
TABLE 162 CANADA: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 145
TABLE 163 CANADA: CELL CULTURE VESSELS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 145
TABLE 164 CANADA: CELL-CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 146
TABLE 165 CANADA: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 146
TABLE 166 CANADA: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 147
TABLE 167 CANADA: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 147
TABLE 168 CANADA: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 147
TABLE 169 CANADA: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 148
TABLE 170 CANADA: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 148
TABLE 171 CANADA: CELL CULTURE MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 149
TABLE 172 CANADA: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 149
TABLE 173 CANADA: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 149
TABLE 174 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION) 152
TABLE 175 EUROPE: CELL CULTURE MARKET SIZE, BY EQUIPMENTS,
2013-2020 (USD MILLION) 152
TABLE 176 EUROPE: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 152
TABLE 177 EUROPE: CELL CULTURE VESSELS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 153
TABLE 178 EUROPE: CELL-CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 153
TABLE 179 EUROPE: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 154
TABLE 180 EUROPE: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 154
TABLE 181 EUROPE: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 155
TABLE 182 EUROPE: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 155
TABLE 183 EUROPE: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 155
TABLE 184 EUROPE: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 156
TABLE 185 EUROPE: CELL CULTURE MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 156
TABLE 186 EUROPE: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 157
TABLE 187 EUROPE: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 157
TABLE 188 ASIA: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION) 160
TABLE 189 ASIA: CELL CULTURE MARKET SIZE, BY EQUIPMENTS, 2013-2020 (USD MILLION) 160
TABLE 190 ASIA: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 160
TABLE 191 ASIA: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 161
TABLE 192 ASIA: CELL CULTURE STORAGE EQUIPMENT MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 161
TABLE 193 ASIA: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 162
TABLE 194 ASIA: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 162
TABLE 195 ASIA: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 163
TABLE 196 ASIA: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 163
TABLE 197 ASIA: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 163
TABLE 198 ASIA: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 164
TABLE 199 ASIA: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 164
TABLE 200 ASIA: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 165
TABLE 201 ASIA: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 165
TABLE 202 ROW: CELL CULTURE MARKET, BY PRODUCT, 2013-2020 (USD MILLION) 167
TABLE 203 ROW: CELL CULTURE MARKET SIZE, BY EQUIPMENTS, 2013-2020 (USD MILLION) 168
TABLE 204 ROW: BIOREACTORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 168
TABLE 205 ROW: CELL CULTURE VESSELS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 169
TABLE 206 ROW: CELL CULTURE STORAGE EQUIPMENT MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 169
TABLE 207 ROW: CELL CULTURE SUPPORTING EQUIPMENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 170
TABLE 208 ROW: CELL CULTURE CONSUMABLES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 170
TABLE 209 ROW: SERA, MEDIA, AND REAGENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 171
TABLE 210 ROW: SERA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 171
TABLE 211 ROW: MEDIA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 171
TABLE 212 ROW: REAGENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 172
TABLE 213 ROW: CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 172
TABLE 214 ROW: BIOPHARMACEUTICAL/THERAPEUTICS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 173
TABLE 215 ROW: CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 173
TABLE 216 NEW PRODUCT LAUNCHES 178
TABLE 217 AGREEMENTS AND COLLABORATIONS 179
TABLE 218 EXPANSIONS 180
TABLE 219 ACQUISITIONS 181
TABLE 220 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD) 192
TABLE 221 EXCHANGE RATES (USED FOR THE CONVERSION OF CHF TO USD) 205
TABLE 222 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD) 224
TABLE 223 EXCHANGE RATES (USED FOR THE CONVERSION OF EURO TO USD) 236
TABLE 224 THERMO FISHER SCIENTIFIC, INC. 245
TABLE 225 MERCK KGAA 246
TABLE 226 GE HEALTHCARE 247
TABLE 227 LONZA GROUP AG 247
TABLE 228 CORNING, INC. 248
TABLE 229 BECTON, DICKINSON AND COMPANY 248
TABLE 230 EPPENDORF AG 249
TABLE 231 SARTORIUS AG 249
TABLE 232 PROMOCELL GMBH 250
“
“LIST OF FIGURES
FIGURE 1 CELL CULTURE MARKET, BY PRODUCT 20
FIGURE 2 CELL CULTURE MARKET, BY INSTRUMENT 20
FIGURE 3 CELL CULTURE MARKET, BY CONSUMABLE 21
FIGURE 4 RESEARCH DESIGN 24
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 25
FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 26
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 26
FIGURE 8 DATA TRIANGULATION METHODOLOGY 27
FIGURE 9 KEY DATA FROM SECONDARY SOURCES 28
FIGURE 10 KEY DATA FROM PRIMARY SOURCES 29
FIGURE 11 CELL CULTURE MARKET SNAPSHOT, BY PRODUCT, 2015 VS. 2020 31
FIGURE 12 BIOPHARMACEUTICAL/THERAPEUTICS IS THE FASTEST-GROWING APPLICATION SEGMENT 32
FIGURE 13 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO HOLD THE LARGEST SHARE DURING THE FORECAST PERIOD (2015-2020) 33
FIGURE 14 CELL CULTURE MARKET, BY REGION: ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 34
FIGURE 15 NEW PRODUCT LAUNCHES & AGREEMENTS AND COLLABORATIONS ARE THE KEY STRATEGIES ADOPTED BY THE MARKET PLAYERS DURING THE FORECAST PERIOD 35
FIGURE 16 GROWING AWARENESS ON THE BENEFITS OF CELL CULTURE-BASED VACCINES—A MAJOR FACTOR DRIVING MARKET GROWTH 36
FIGURE 17 MARKET SHARE (2015) FOR TOP FOUR CELL CULTURE VESSELS 37
FIGURE 18 FETAL BOVINE SERA TO WITNESS THE HIGHEST GROWTH FROM 2015 TO 2020 38
FIGURE 19 BIOPHARMACEUTICAL/THERAPEUTICS SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 39
FIGURE 20 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 39
FIGURE 21 ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 40
FIGURE 22 CELL CULTURE MARKET, BY PRODUCT 42
FIGURE 23 CELL CULTURE MARKET, BY EQUIPMENT 43
FIGURE 24 CELL CULTURE MARKET, BY CONSUMABLE 43
FIGURE 25 CELL CULTURE MARKET, BY APPLICATION 44
FIGURE 26 CELL CULTURE MARKET, BY END USER 44
FIGURE 27 CELL CULTURE MARKET SEGMENTATION, BY REGION 44
FIGURE 28 CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
FIGURE 29 CONSUMABLES TO DOMINATE CELL CULTURE PRODUCTS MARKET 52
FIGURE 30 BIOREACTORS TO WITNESS HIGHEST GROWTH IN CELL CULTURE EQUIPMENT MARKET 53
FIGURE 31 CONVENTIONAL BIOREACTORS TO DOMINATE THE MARKET DURING FORECAST PERIOD (2015-2020) 55
FIGURE 32 ROLLER BOTTLES/ROUX BOTTLES TO DOMINATE CELL CULTURE VESSEL MARKET 59
FIGURE 33 REFRIGERATORS & FREEZERS TO COMMAND LARGEST SHARE OF CELL CULTURE MARKET BY EQUIPMENT IN 2015 66
FIGURE 34 FILTRATION SYSTEMS TO DOMINATE THE CELL CULTURE SUPPORTING EQUIPMENT MARKET 70
FIGURE 35 ASIA TO WITNESS HIGHEST GROWTH RATE IN CELL CULTURE CONSUMABLE MARKET 82
FIGURE 36 FETAL BOVINE SERA (FBS) TO DOMINATE THE CELL CULTURE SERA MARKET DURING 2015-2020 86
FIGURE 37 SUPPLEMENTS AND GROWTH FACTORS TO DOMINATE THE REAGENT MARKET 97
FIGURE 38 BIOPHARMACEUTICALS/THERAPEUTICS APPLICATION SEGMENT TO DOMINATE CELL CULTURE MARKET DURING THE FORECAST PERIOD (2015-2020) 110
FIGURE 39 VACCINE PRODUCTION TO COMMAND LARGEST SHARE OF THE BIOPHARMACEUTICAL/THERAPEUTICS MARKET 111
FIGURE 40 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE CELL CULTURE MARKET FROM 2015 TO 2020 124
FIGURE 41 ASIA TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2015-2020) 129
FIGURE 42 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT (2015) 131
FIGURE 43 EUROPE: CELL CULTURE MARKET SNAPSHOT (2015) 151
FIGURE 44 ASIA: CELL CULTURE MARKET SNAPSHOT (2015) 159
FIGURE 45 REST OF THE WORLD (ROW): CELL CULTURE MARKET SNAPSHOT (2015) 167
FIGURE 46 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2012 AND 2015 174
FIGURE 47 MARKET EVOLUTION FRAMEWORK 175
FIGURE 48 MARKET SHARE OF KEY PLAYERS IN THE CELL CULTURE SERA, MEDIA, & REAGENTS MARKET (2014) 176
FIGURE 49 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY THE MARKET PLAYERS 177
FIGURE 50 GEOGRAPHIC REVENUE MIX OF KEY PLAYERS 182
FIGURE 51 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC. 183
FIGURE 52 COMPANY SNAPSHOT: MERCK MILLIPORE 192
FIGURE 53 COMPANY SNAPSHOT: GE HEALTHCARE 200
FIGURE 54 COMPANY SNAPSHOT: LONZA GROUP AG 205
FIGURE 55 COMPANY SNAPSHOT: CORNING, INC. 209
FIGURE 56 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY 219
FIGURE 57 COMPANY SNAPSHOT: EPPENDORF AG 223
FIGURE 58 COMPANY SNAPSHOT: SARTORIUS AG 235
“
- Previous: Small Drones Market by Application (Defense, Commercial), Size (Micro, Mini, Nano), Payload (Sensor, Telemetry System, Camera, Videoscreen, NBC Detection, SAR, Others), Type, Propulsion Systems, & Region – Global Forecasts to 2020
- Next: Global Bedsheets Industry 2016 Market Research Report
